Martínez-Maza O - Search Results

1

Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Becker N, Falster MO, Vajdic CM, de Sanjose S, Martínez-Maza O, Bracci PM, Melbye M, Smedby KE, Engels EA, Turner J, Vineis P, Costantini AS, Holly EA, Spinelli JJ, La Vecchia C, Zheng T, Chiu BC, Montella M, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Cozen W, Grulich AE, Newton R. Becker N, et al. Int J Cancer. 2012 Nov 15;131(10):2342-8. doi: 10.1002/ijc.27438. Epub 2012 Aug 12. Int J Cancer. 2012. PMID: 22266776 Free PMC article.

2

Immune dysfunction and the pathogenesis of AIDS-associated non-Hodgkin's lymphoma.

Martínez-Maza O, Widney D, van der Meijden M, Knox R, Echeverri A, Breen EC, Magpantay L, Miles SA. Martínez-Maza O, et al. Mem Inst Oswaldo Cruz. 1998 May-Jun;93(3):373-81. doi: 10.1590/s0074-02761998000300019. Mem Inst Oswaldo Cruz. 1998. PMID: 9698872 Free article.

3

The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6.

Breen EC, van der Meijden M, Cumberland W, Kishimoto T, Detels R, Martínez-Maza O. Breen EC, et al. Clin Immunol. 1999 Sep;92(3):293-9. doi: 10.1006/clim.1999.4760. Clin Immunol. 1999. PMID: 10479534

4

Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.

Schroeder JR, Saah AJ, Hoover DR, Margolick JB, Ambinder RF, Martinez-Maza O, Breen EC, Jacobson LP, Variakojis D, Rowe DT, Armenian HK. Schroeder JR, et al. Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):979-84. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10566552

5

B-cell activation and lymphoma in patients with HIV.

Martínez-Maza O, Breen EC. Martínez-Maza O, et al. Curr Opin Oncol. 2002 Sep;14(5):528-32. doi: 10.1097/00001622-200209000-00009. Curr Opin Oncol. 2002. PMID: 12192272 Review.

6

Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype.

Breen EC, Boscardin WJ, Detels R, Jacobson LP, Smith MW, O'Brien SJ, Chmiel JS, Rinaldo CR, Lai S, Martínez-Maza O. Breen EC, et al. Clin Immunol. 2003 Nov;109(2):119-29. doi: 10.1016/s1521-6616(03)00214-6. Clin Immunol. 2003. PMID: 14597210

7

Occupational exposure to immunologically active agents and risk for lymphoma.

Kogevinas M, Zock JP, Alvaro T, Garcia-Villanueva M, Domingo-Domenech E, Kennedy S, Martínez-Maza O, de Sanjose S. Kogevinas M, et al. Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1814-8. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15533913

8

Elevated levels of soluble CD44 precede the development of AIDS-associated non-Hodgkin's B-cell lymphoma.

Breen EC, Epeldegui M, Boscardin WJ, Widney DP, Detels R, Martínez-Maza O. Breen EC, et al. AIDS. 2005 Oct 14;19(15):1711-2. doi: 10.1097/01.aids.0000184924.04983.7c. AIDS. 2005. PMID: 16184051 No abstract available.

9

Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma.

Breen EC, Fatahi S, Epeldegui M, Boscardin WJ, Detels R, Martínez-Maza O. Breen EC, et al. Tumour Biol. 2006;27(4):187-94. doi: 10.1159/000093022. Epub 2006 Apr 27. Tumour Biol. 2006. PMID: 16651853

10

The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk.

Cozen W, Cerhan JR, Martinez-Maza O, Ward MH, Linet M, Colt JS, Davis S, Severson RK, Hartge P, Bernstein L. Cozen W, et al. Cancer Causes Control. 2007 Oct;18(8):821-31. doi: 10.1007/s10552-007-9025-5. Epub 2007 Jun 22. Cancer Causes Control. 2007. PMID: 17588155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters